Blog
RSS FeedPosted by Michael Wonder on 09 Jun 2021
AMA and Australian Government agree to strengthening the MBS review process and informed financial consent
8 June 2021 - The Australian Government and the Australian Medical Association have reached agreement to work together to co-design the ...
Posted by Michael Wonder on 30 Apr 2021
Cancer expert to head review into efficient and equitable access to chemotherapy medicines
1 May 2021 - Renowned cancer expert Professor Sanchia Aranda AM will head an Australian Government review aimed at making ...
Posted by Michael Wonder on 30 Apr 2021
Bristol Myers Squibb statement on FDA Advisory Committee meeting on Opdivo post sorafenib hepatocellular carcinoma U.S. indication
29 April 2021 - As part of its industry-wide review of accelerated approvals in oncology without confirmatory benefit, the U.S ...
Posted by Michael Wonder on 28 Apr 2021
FDA Advisory Committee votes in favour of maintaining accelerated approval of Genentech’s Tecentriq for PD-L1 positive, metastatic triple negative breast cancer
27 April 2021 - Genentech today announced the U.S. FDA Oncologic Drugs Advisory Committee voted 7 to 2 in favour of ...
Posted by Michael Wonder on 20 Apr 2021
Major health sector shake-up: Government scraps all district health boards in favour of one national authority
21 April 2021 - All of New Zealand's 20 District Health Boards will be replaced by one, single national health ...
Posted by Michael Wonder on 14 Mar 2021
PHARMAC review misses political elephant in the room
13 March 2021 - The governments of many developed nations fund medicines for their citizens after they have gone through independent ...
Posted by Michael Wonder on 08 Mar 2021
Pacific pharmacists want inclusion on PHARMAC review
6 March 2021 - The President of the Pacific Pharmacists’Association, Kasey Brown, says a review of New Zealand’s drug buying ...
Posted by Michael Wonder on 07 Mar 2021
Cancer Society says PHARMAC review doesn't go far enough
3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue. ...
Posted by Michael Wonder on 04 Mar 2021
The PHARMAC non-review?
4 March 2021 - The recently announced PHARMAC review is fatally flawed. ...
Posted by Michael Wonder on 03 Mar 2021
PHARMAC ripe for reassessment
3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...
Posted by Michael Wonder on 02 Mar 2021
Government announces review into PHARMAC
2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...
Posted by Michael Wonder on 02 Mar 2021
Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise
2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...
Posted by Michael Wonder on 01 Mar 2021
Review asks how Government can get the new drugs it wants funded
2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 17 Feb 2021
TLV is tasked with reducing costs for medicines
16 February 2021 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency, TLV, to implement measures to reduce ...